Mizuho lowered the firm’s price target on Humana (HUM) to $310 from $345 and keeps an Outperform rating on the shares.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HUM:
- Humana price target lowered to $231 from $250 at Deutsche Bank
- Humana’s Hold Rating: Balancing Positive Earnings with Strategic Challenges
- Humana’s Strategic Focus on Medicare Advantage and Future Margin Expansion Amidst Uncertain Guidance
- Humana’s Growth Prospects and Risks: Hold Rating Amid Unclear 2026 Projections and MLR Challenges
- Humana Reports Strong Q3 2025 Results Amid Strategic Growth